miR-124 Represses the Mesenchymal Features and Suppresses Metastasis in Ewing Sarcoma

Oncotarget - United States
doi 10.18632/oncotarget.14394
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

miR-125b Develops Chemoresistance in Ewing Sarcoma/Primitive Neuroectodermal Tumor

Cancer Cell International
Cancer ResearchOncologyGenetics
2013English

Hsa‑miR‑24 Suppresses Metastasis in Nasopharyngeal Carcinoma by Regulating the C‑Myc/Epithelial‑mesenchymal Transition Axis

Oncology Reports
MedicineCancer ResearchOncology
2018English

The Pathogenesis of Ewing Sarcoma. Implications of Mesenchymal Stem Cells and New Therapeutic Strategies

English

Targeted Therapy in Ewing Sarcoma

ISRN Oncology
2012English

The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer

Cancer Research
Cancer ResearchOncology
2016English

Primary Ewing Sarcoma of the Larynx With Distant Metastasis: A Case Report and Review of the Literature

Current Oncology
Oncology
2019English

Clinical and Molecular Features of Ewing Sarcoma in a Patient With Triple-X Syndrome

Cancer Genetics and Cytogenetics
1999English

miR‑202 Suppresses Prostate Cancer Growth and Metastasis by Targeting PIK3CA

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

MiR-198 Represses Tumor Growth and Metastasis in Colorectal Cancer by Targeting Fucosyl Transferase 8

Scientific Reports
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy